Insomnia is the most widespread sleep disorder in the Quebec population - epidemiological surveys indicate that around 30 % of adults present with insomnia symptoms, and that 10 to 15 % suffer from clinically significant chronic insomnia, defined as difficulties in falling asleep, maintaining sleep or waking up early in the morning, occurring at least three nights a week for more than three months, and resulting in suffering or impaired daytime functioning. Despite this considerable prevalence, insomnia is often under-treated - many sufferers don't tell their doctor, get used to functioning with insufficient sleep, or self-medicate with over-the-counter products of limited long-term efficacy.
Insomnia is not just a nuisance - it's a medical condition with documented physiological and psychological consequences: impaired cognitive function and concentration, irritability and emotional instability, increased risk of depression and anxiety, increased blood pressure and cardiovascular risk, disruption of carbohydrate metabolism, weakened immune defenses, and risk of daytime sleep-related accidents. The good news is that chronic insomnia is a highly treatable condition - and that the most effective treatments are not sleeping pills, contrary to what many patients assume, but specific psychotherapeutic approaches whose effectiveness is now firmly established.
Causes of insomnia: identifying medical, psychological and behavioral factors
Insomnia is rarely monocausal - more often than not, it results from the interaction between predisposing, precipitating and perpetuating factors, according to the 3P model developed by Arthur Spielman. Predisposing factors are individual characteristics that increase vulnerability to insomnia: physiological hyperactivation of the arousal system, tendency to anxiety and rumination, family history of sleep disorders. Precipitating factors trigger acute insomnia: stressful events - separation, bereavement, job loss, illness -, schedule changes, trans-meridian travel, acute pain, hospitalization. Perpetuating factors maintain insomnia beyond the triggering event and explain its chronicization: maladaptive behaviors such as staying in bed for long periods without sleeping, compensatory daytime naps, catastrophization of the consequences of sleep deprivation, performance anxiety at bedtime.
From a medical point of view, many conditions can disrupt sleep and should be investigated when assessing insomnia: major depression - often manifested by early awakenings at the end of the night -, anxiety disorders - with difficulty falling asleep and nocturnal ruminations -, chronic pain of any origin - osteoarthritis, low back pain, fibromyalgia -, obstructive sleep apnea - fragmenting sleep through repeated micro-awakenings -, restless legs syndrome - uncomfortable sensations in the lower limbs forcing movement -, hyperthyroidism, heart disease with nocturnal dyspnea, and the undesirable effects of many drugs: corticosteroids, beta-blockers, nocturnal diuretics, certain activating antidepressants, decongestants, caffeine and alcohol. Identifying and treating these underlying causes is often the key to a lasting resolution of insomnia.
Cognitive behavioral therapy for insomnia: the first-line treatment
Cognitive Behavioral Therapy for Insomnia - CBT-I - is recognized by all sleep medicine societies as the first-line treatment for chronic insomnia, superior to sleeping pills over the long term and without the side effects associated with medication. CBT-I is a structured program - typically 6 to 8 sessions - that combines several complementary interventions. Sleep restriction is the most powerful but also the most counter-intuitive component: it involves temporarily limiting the time spent in bed to the actual estimated sleep time, creating a sleep debt that increases sleep pressure and consolidates fragmented sleep into a more compact and efficient period. Stimulus control aims to dissociate the bed from wakefulness and anxiety by reserving the bed for sleep and sexual activities only - leaving the bed if sleep does not occur within 20 minutes.
The cognitive component of CBT-I addresses the dysfunctional beliefs and attitudes about sleep that fuel nocturnal performance anxiety: the belief that it's imperative to get exactly 8 hours of sleep, catastrophizing about the consequences of a bad night's sleep, attributing all daytime functioning problems to lack of sleep. Psycho-education on sleep - sleep cycles, normal variability, sleep hygiene - completes the approach. CBT-I delivered by a trained psychologist or physician is the optimal modality, but validated digital versions - mobile apps and online programs - have demonstrated significant efficacy and may represent an accessible alternative in the absence of an available therapist or while awaiting treatment. The Clinique Omicron physician can initiate the basic elements of CBT-I, prescribe validated digital resources, and coordinate sleep psychology referral when necessary.
Insomnia drugs: what do we need to know in 2026?
Sleeping pills can play a useful role in the management of acute insomnia - for example, during an identified stressful event or to break a cycle of severe insomnia - but their long-term use in chronic insomnia is discouraged by the majority of current clinical practice guidelines. Benzodiazepines - lorazepam, temazepam, nitrazepam - and Z molecules - zopiclone, zolpidem - are effective in the short term for inducing and maintaining sleep, but their prolonged use is associated with pharmacological tolerance - the need to increase doses for the same effect - physical dependence with withdrawal syndrome on discontinuation, rebound insomnia, daytime sedation and memory impairment, and a significantly increased risk of falls and fractures in the elderly. Progressive deprescription of benzodiazepine hypnotics, when prescribed long-term, is a medical priority - ideally carried out in combination with CBT-I.
Extended-release melatonin - Circadin - is approved in Canada for the short-term treatment of insomnia in adults aged 55 and over, and has an excellent safety profile with no dependence or rebound. Its efficacy is modest but real, particularly in improving subjective sleep quality and reducing time to sleep. Over-the-counter immediate-release melatonin has less solid evidence of efficacy for chronic insomnia, but may be useful for circadian rhythm disorders - jet lag, shift work. The new orexin receptor antagonists - suvorexant, lemborexant - represent a more recent therapeutic class with a different mechanism of action from benzodiazepines and a potentially more favorable tolerance profile, but their availability and coverage by drug insurance plans in Quebec remain variable.
Frequently asked questions about insomnia and medical consultation
When is it really necessary to consult a doctor about insomnia?
A medical consultation is recommended when insomnia has lasted for more than four weeks and significantly affects daytime functioning - concentration, mood, performance at work or school, interpersonal relationships - when it is accompanied by symptoms that could indicate an underlying cause - intense snoring and nocturnal breathing pauses suggesting sleep apnea, impatience in the legs at bedtime, fever, aches and pains, symptoms of depression or anxiety - when self-medication with over-the-counter products proves insufficient or you feel the need to increase doses, or when insomnia is associated with excessive daytime sleepiness despite sufficient bedtime - the latter sign may indicate a primary sleep disorder such as apnea or narcolepsy. A medical consultation helps to distinguish between primary and secondary insomnia, to direct the patient towards the most appropriate treatments, and to avoid escalation to inappropriate sleeping pills.
Does alcohol help or worsen insomnia?
Alcohol has an initial sedative effect that makes it easier to fall asleep - which is why many insomnia sufferers use it as a sleep aid - but its effects on sleep architecture are negative overall. Alcohol suppresses REM sleep in the first half of the night and causes a rebound effect in the second half, with more light sleep, micro-awakenings and vivid dreams. The result is less restorative sleep overall, with wakefulness often early and difficult despite apparently normal sleep duration. Alcohol also significantly aggravates snoring and sleep apnea by relaxing the muscles of the upper airways. Regular use of alcohol as a sleep aid quickly leads to tolerance - you need more and more to get the same sedative effect - and can contribute to dependence. Sleep hygiene recommendations include limiting alcohol consumption to less than two standard glasses, and avoiding all consumption within four hours of bedtime.
My child or teenager suffers from insomnia - how common is it and what can I do about it?
Sleep disorders in children and adolescents are indeed common, but often under-recognized. In pre-school and school-age children, difficulties in falling asleep on their own, nocturnal awakenings and bedtime resistance are frequent, and often linked to behavioral factors - inappropriate sleep associations, irregular schedules, excessive evening stimulation. In adolescents, phase delay - the physiological tendency to fall asleep and wake up later as a result of the hormonal changes associated with puberty - combined with early-morning school constraints creates a chronic structural sleep debt. Teenage insomnia is also frequently associated with anxiety disorders, depression, excessive use of screens in the evening - blue light inhibits melatonin - and caffeine. Medical consultation is recommended when the sleep problem has lasted for more than a few weeks and is affecting the child's mood, school performance or behavior - age-appropriate behavioral approaches are generally very effective.
Omicron Clinic
Need to consult a doctor?
Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.
Insurance receipts. 7j/7. No family doctor required.
